FDC Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: June 13, 2025, 9:30 pm

Market Cap	7,755 Cr.
Current Price	476
High / Low	659/359
Stock P/E	29.1
Book Value	140
Dividend Yield	1.05 %
ROCE	16.4 %
ROE	12.2 %
Face Value	1.00
PEG Ratio	-25.38

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for FDC Ltd

Competitors of FDC Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Lactose (India) Ltd	139 Cr.	98.4	247/84.3	26.9	41.7	0.00 %	12.9 %	9.75 %	10.0
MPS Pharmaa Ltd	5.27 Cr.	2.76	4.33/2.50		0.57	0.00 %	9.79 %	59.0 %	10.0
Gujarat Themis Biosyn Ltd	2,663 Cr.	244	390/192	50.6	20.5	0.27 %	45.0 %	33.8 %	1.00
Gujarat Terce Laboratories Ltd	41.6 Cr.	56.0	94.9/44.5		8.73	0.00 %	41.5 %	14.4 %	10.0
Gujarat Inject (Kerala) Ltd	32.1 Cr.	21.9	29.1/13.1	31.4	6.83	0.00 %	13.5 %	11.0 %	10.0
Industry Average	18,999.74 Cr	1,191.55		92.42	194.72	0.30%	16.67%	15.20%	6.18

All Competitor Stocks of FDC Ltd

Quarterly Result

Metric	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Sales	341	495	445	409	435	536	486	458	462	638	514	464	492
Expenses	322	417	378	360	386	414	410	374	406	492	444	417	438
Operating Profit	19	78	67	49	49	122	76	84	56	147	70	47	54
OPM %	6%	16%	15%	12%	11%	23%	16%	18%	12%	23%	14%	10%	11%
Other Income	10	19	13	18	7	29	27	25	20	28	35	19	16
Interest	1	1	1	1	1	1	1	1	1	1	1	1	1
Depreciation	9	9	10	10	10	10	10	10	10	11	14	13	16
Profit before tax	19	87	69	57	45	141	93	98	65	163	90	51	53
Tax %	45%	19%	25%	28%	32%	22%	25%	19%	29%	27%	20%	28%	27%
Net Profit	10	71	52	41	31	110	70	79	46	119	72	37	39
EPS in Rs	0.62	4.26	3.12	2.46	1.85	6.62	4.29	4.87	2.84	7.31	4.42	2.28	2.38

Last Updated: May 31, 2025, 9:17 am

Below is a detailed analysis of the quarterly data for FDC Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

For Sales, as of Mar 2025, the value is 492.00 Cr.. The value appears strong and on an upward trend. It has increased from 464.00 Cr. (Dec 2024) to 492.00 Cr., marking an increase of 28.00 Cr..
For Expenses, as of Mar 2025, the value is 438.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 417.00 Cr. (Dec 2024) to 438.00 Cr., marking an increase of 21.00 Cr..
For Operating Profit, as of Mar 2025, the value is 54.00 Cr.. The value appears strong and on an upward trend. It has increased from 47.00 Cr. (Dec 2024) to 54.00 Cr., marking an increase of 7.00 Cr..
For OPM %, as of Mar 2025, the value is 11.00%. The value appears strong and on an upward trend. It has increased from 10.00% (Dec 2024) to 11.00%, marking an increase of 1.00%.
For Other Income, as of Mar 2025, the value is 16.00 Cr.. The value appears to be declining and may need further review. It has decreased from 19.00 Cr. (Dec 2024) to 16.00 Cr., marking a decrease of 3.00 Cr..
For Interest, as of Mar 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 1.00 Cr..
For Depreciation, as of Mar 2025, the value is 16.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 13.00 Cr. (Dec 2024) to 16.00 Cr., marking an increase of 3.00 Cr..
For Profit before tax, as of Mar 2025, the value is 53.00 Cr.. The value appears strong and on an upward trend. It has increased from 51.00 Cr. (Dec 2024) to 53.00 Cr., marking an increase of 2.00 Cr..
For Tax %, as of Mar 2025, the value is 27.00%. The value appears to be improving (decreasing) as expected. It has decreased from 28.00% (Dec 2024) to 27.00%, marking a decrease of 1.00%.
For Net Profit, as of Mar 2025, the value is 39.00 Cr.. The value appears strong and on an upward trend. It has increased from 37.00 Cr. (Dec 2024) to 39.00 Cr., marking an increase of 2.00 Cr..
For EPS in Rs, as of Mar 2025, the value is 2.38. The value appears strong and on an upward trend. It has increased from 2.28 (Dec 2024) to 2.38, marking an increase of 0.10.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 6, 2025, 4:21 pm

Metric	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Sales	772	845	888	994	1,013	1,074	1,089	1,341	1,331	1,525	1,784	1,943	2,078
Expenses	591	638	690	765	769	841	860	1,038	997	1,271	1,533	1,604	1,759
Operating Profit	181	207	199	229	243	233	229	304	334	254	251	339	320
OPM %	23%	24%	22%	23%	24%	22%	21%	23%	25%	17%	14%	17%	15%
Other Income	46	39	46	39	44	45	42	57	95	76	50	102	102
Interest	2	3	2	1	1	1	1	3	3	3	4	4	4
Depreciation	28	25	39	34	35	35	33	37	38	37	39	40	49
Profit before tax	198	218	204	232	252	241	237	320	388	289	258	396	369
Tax %	22%	38%	27%	27%	25%	28%	28%	25%	22%	25%	25%	23%
Net Profit	155	135	148	169	189	174	170	240	301	216	194	305	274
EPS in Rs	8.49	7.61	8.33	9.48	10.60	9.95	9.74	14.03	17.85	12.82	11.70	18.75	16.85
Dividend Payout %	26%	30%	27%	24%	21%	0%	0%	6%	0%	0%	0%	0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2013-2014	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024
YoY Net Profit Growth (%)	-12.90%	9.63%	14.19%	11.83%	-7.94%	-2.30%	41.18%	25.42%	-28.24%	-10.19%	57.22%
Change in YoY Net Profit Growth (%)	0.00%	22.53%	4.56%	-2.35%	-19.77%	5.64%	43.48%	-15.76%	-53.66%	18.05%	67.40%

FDC Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:	9%
5 Years:	9%
3 Years:	11%
TTM:	9%

Compounded Profit Growth
10 Years:	7%
5 Years:	3%
3 Years:	8%
TTM:	-8%

Stock Price CAGR
10 Years:	12%
5 Years:	14%
3 Years:	26%
1 Year:	4%

Return on Equity
10 Years:	14%
5 Years:	13%
3 Years:	12%
Last Year:	12%

Last Updated: Unknown

Balance Sheet

Last Updated: June 12, 2025, 3:32 pm

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	18	18	18	18	18	18	17	17	17	17	16	16
Reserves	827	919	1,065	1,252	1,259	1,428	1,530	1,717	1,940	1,965	2,081	2,265
Borrowings	3	2	1	1	1	1	15	15	32	28	21	21
Other Liabilities	211	210	182	197	228	194	250	207	281	333	350	412
Total Liabilities	1,059	1,148	1,266	1,468	1,505	1,640	1,813	1,956	2,270	2,343	2,468	2,714
Fixed Assets	284	393	675	678	674	682	674	689	705	699	680	852
CWIP	18	29	20	6	13	12	24	19	105	198	261	136
Investments	417	489	325	491	471	585	665	790	886	806	843	1,028
Other Assets	340	237	246	293	348	360	451	458	575	640	684	698
Total Assets	1,059	1,148	1,266	1,468	1,505	1,640	1,813	1,956	2,270	2,343	2,468	2,714

Below is a detailed analysis of the balance sheet data for FDC Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

For Equity Capital, as of Mar 2025, the value is 16.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 16.00 Cr..
For Reserves, as of Mar 2025, the value is 2,265.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,081.00 Cr. (Mar 2024) to 2,265.00 Cr., marking an increase of 184.00 Cr..
For Borrowings, as of Mar 2025, the value is 21.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2024) which recorded 21.00 Cr..
For Other Liabilities, as of Mar 2025, the value is 412.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 350.00 Cr. (Mar 2024) to 412.00 Cr., marking an increase of 62.00 Cr..
For Total Liabilities, as of Mar 2025, the value is 2,714.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,468.00 Cr. (Mar 2024) to 2,714.00 Cr., marking an increase of 246.00 Cr..
For Fixed Assets, as of Mar 2025, the value is 852.00 Cr.. The value appears strong and on an upward trend. It has increased from 680.00 Cr. (Mar 2024) to 852.00 Cr., marking an increase of 172.00 Cr..
For CWIP, as of Mar 2025, the value is 136.00 Cr.. The value appears to be declining and may need further review. It has decreased from 261.00 Cr. (Mar 2024) to 136.00 Cr., marking a decrease of 125.00 Cr..
For Investments, as of Mar 2025, the value is 1,028.00 Cr.. The value appears strong and on an upward trend. It has increased from 843.00 Cr. (Mar 2024) to 1,028.00 Cr., marking an increase of 185.00 Cr..
For Other Assets, as of Mar 2025, the value is 698.00 Cr.. The value appears strong and on an upward trend. It has increased from 684.00 Cr. (Mar 2024) to 698.00 Cr., marking an increase of 14.00 Cr..
For Total Assets, as of Mar 2025, the value is 2,714.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,468.00 Cr. (Mar 2024) to 2,714.00 Cr., marking an increase of 246.00 Cr..

Notably, the Reserves (2,265.00 Cr.) exceed the Borrowings (21.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity +	150	128	174	154	150	112	250	207	162	155	221	318
Cash from Investing Activity +	-55	-89	-73	-144	21	-121	-98	-77	-145	11	-17	-200
Cash from Financing Activity +	-75	-48	-97	0	-169	-0	-142	-129	-10	-180	-202	-92
Net Cash Flow	19	-9	4	11	1	-8	10	1	7	-14	2	26

Free Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Free Cash Flow	181.00	204.00	197.00	228.00	242.00	232.00	228.00	289.00	319.00	222.00	223.00	318.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	20	26	25	23	27	28	29	34	30	20	25	22
Inventory Days	117	116	132	134	148	166	184	180	189	210	183	216
Days Payable	72	90	94	84	81	101	82	101	68	94	99	103
Cash Conversion Cycle	66	51	64	72	94	93	131	113	152	135	109	135
Working Capital Days	24	2	11	21	23	29	45	41	50	47	49	139
ROCE %	23%	25%	21%	22%	21%	19%	17%	21%	22%	15%	13%	19%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Promoters	69.36%	69.50%	69.49%	69.49%	69.49%	69.49%	69.66%	69.66%	69.66%	69.66%	69.66%	69.66%
FIIs	4.52%	4.34%	3.99%	3.77%	3.80%	2.06%	2.42%	2.43%	2.65%	2.51%	2.62%	2.67%
DIIs	5.86%	6.07%	6.77%	7.76%	8.27%	9.13%	8.12%	7.76%	6.94%	6.72%	6.02%	6.08%
Public	20.27%	20.09%	19.75%	18.98%	18.44%	19.32%	19.80%	20.15%	20.76%	21.11%	21.71%	21.60%
No. of Shareholders	86,503	65,318	63,172	59,871	57,012	56,717	56,928	55,341	52,377	50,634	55,400	55,228

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund Name	No of Shares	AUM (%)	Amount Invested (Cr)	Previous Number of Shares	Previous Date	Percentage Change
Nippon India Small Cap Fund	4,257,262	0.41	154.24	4,257,262	2025-04-22 17:25:36	0%
ICICI Prudential Smallcap Fund	1,509,088	0.91	54.67	1,509,088	2025-04-22 17:25:36	0%
ICICI Prudential Multi Asset Fund	704,002	0.1	25.51	704,002	2025-04-22 17:25:36	0%
Bandhan Emerging Businesses Fund	525,874	0.85	19.05	525,874	2025-04-22 17:25:36	0%
ICICI Prudential Multicap Fund	467,004	0.19	16.92	467,004	2025-04-22 17:25:36	0%
Samco Active Momentum Fund	429,098	3.61	15.55	429,098	2025-04-22 15:56:58	0%
ITI Pharma and Healthcare Fund	69,869	1.97	2.53	69,869	2025-04-22 15:56:58	0%
Nippon India Nifty Smallcap 250 Index Fund	30,083	0.15	1.09	30,083	2025-04-22 17:25:36	0%
Motilal Oswal Nifty Smallcap 250 Index Fund	18,887	0.15	0.68	18,887	2025-04-22 17:25:36	0%
SBI Nifty Smallcap 250 Index Fund	13,865	0.15	0.5	13,865	2025-04-22 15:56:58	0%

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	1.00	1.00	1.00	1.00	1.00
Basic EPS (Rs.)	18.58	11.66	12.81	17.72	13.94
Diluted EPS (Rs.)	18.58	11.66	12.81	17.72	13.94
Cash EPS (Rs.)	21.19	14.03	15.01	20.08	16.28
Book Value[Excl.RevalReserv]/Share (Rs.)	128.81	119.43	115.89	102.72	90.51
Book Value[Incl.RevalReserv]/Share (Rs.)	128.81	119.43	115.89	102.72	90.51
Revenue From Operations / Share (Rs.)	119.34	107.51	90.51	78.98	78.62
PBDIT / Share (Rs.)	27.04	18.13	19.54	25.54	21.16
PBIT / Share (Rs.)	24.58	15.79	17.33	23.30	18.97
PBT / Share (Rs.)	24.34	15.54	17.14	22.97	18.77
Net Profit / Share (Rs.)	18.74	11.68	12.81	17.84	14.09
NP After MI And SOA / Share (Rs.)	18.75	11.70	12.82	17.85	14.03
PBDIT Margin (%)	22.65	16.86	21.58	32.33	26.91
PBIT Margin (%)	20.60	14.68	19.14	29.49	24.13
PBT Margin (%)	20.39	14.45	18.94	29.08	23.87
Net Profit Margin (%)	15.70	10.86	14.14	22.59	17.92
NP After MI And SOA Margin (%)	15.70	10.87	14.16	22.60	17.84
Return on Networth / Equity (%)	14.55	9.78	11.05	17.37	15.50
Return on Capital Employeed (%)	18.55	12.89	14.63	22.44	20.70
Return On Assets (%)	12.36	8.28	9.53	15.40	13.23
Asset Turnover Ratio (%)	0.80	0.77	0.72	0.70	0.77
Current Ratio (X)	3.43	3.30	3.67	4.58	3.76
Quick Ratio (X)	2.18	2.24	2.56	3.52	2.91
Inventory Turnover Ratio (X)	1.63	1.85	1.75	1.64	1.77
Dividend Payout Ratio (NP) (%)	0.00	0.00	0.00	0.00	5.71
Dividend Payout Ratio (CP) (%)	0.00	0.00	0.00	0.00	4.94
Earning Retention Ratio (%)	0.00	0.00	0.00	0.00	94.29
Cash Earning Retention Ratio (%)	0.00	0.00	0.00	0.00	95.06
Interest Coverage Ratio (X)	109.11	73.60	106.74	125.53	105.92
Interest Coverage Ratio (Post Tax) (X)	76.62	48.42	70.97	89.32	71.51
Enterprise Value (Cr.)	6886.08	4231.47	4298.40	4791.75	3318.24
EV / Net Operating Revenue (X)	3.54	2.37	2.81	3.59	2.47
EV / EBITDA (X)	15.64	14.07	13.03	11.12	9.17
MarketCap / Net Operating Revenue (X)	3.56	2.39	2.84	3.62	2.49
Retention Ratios (%)	0.00	0.00	0.00	0.00	94.28
Price / BV (X)	3.30	2.15	2.22	2.78	2.17
Price / Net Operating Revenue (X)	3.56	2.39	2.84	3.62	2.49
EarningsYield	0.04	0.04	0.04	0.06	0.07

After reviewing the key financial ratios for FDC Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 24, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 1.00.
For Basic EPS (Rs.), as of Mar 24, the value is 18.58. This value is within the healthy range. It has increased from 11.66 (Mar 23) to 18.58, marking an increase of 6.92.
For Diluted EPS (Rs.), as of Mar 24, the value is 18.58. This value is within the healthy range. It has increased from 11.66 (Mar 23) to 18.58, marking an increase of 6.92.
For Cash EPS (Rs.), as of Mar 24, the value is 21.19. This value is within the healthy range. It has increased from 14.03 (Mar 23) to 21.19, marking an increase of 7.16.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 128.81. It has increased from 119.43 (Mar 23) to 128.81, marking an increase of 9.38.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 128.81. It has increased from 119.43 (Mar 23) to 128.81, marking an increase of 9.38.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 119.34. It has increased from 107.51 (Mar 23) to 119.34, marking an increase of 11.83.
For PBDIT / Share (Rs.), as of Mar 24, the value is 27.04. This value is within the healthy range. It has increased from 18.13 (Mar 23) to 27.04, marking an increase of 8.91.
For PBIT / Share (Rs.), as of Mar 24, the value is 24.58. This value is within the healthy range. It has increased from 15.79 (Mar 23) to 24.58, marking an increase of 8.79.
For PBT / Share (Rs.), as of Mar 24, the value is 24.34. This value is within the healthy range. It has increased from 15.54 (Mar 23) to 24.34, marking an increase of 8.80.
For Net Profit / Share (Rs.), as of Mar 24, the value is 18.74. This value is within the healthy range. It has increased from 11.68 (Mar 23) to 18.74, marking an increase of 7.06.
For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 18.75. This value is within the healthy range. It has increased from 11.70 (Mar 23) to 18.75, marking an increase of 7.05.
For PBDIT Margin (%), as of Mar 24, the value is 22.65. This value is within the healthy range. It has increased from 16.86 (Mar 23) to 22.65, marking an increase of 5.79.
For PBIT Margin (%), as of Mar 24, the value is 20.60. This value exceeds the healthy maximum of 20. It has increased from 14.68 (Mar 23) to 20.60, marking an increase of 5.92.
For PBT Margin (%), as of Mar 24, the value is 20.39. This value is within the healthy range. It has increased from 14.45 (Mar 23) to 20.39, marking an increase of 5.94.
For Net Profit Margin (%), as of Mar 24, the value is 15.70. This value exceeds the healthy maximum of 10. It has increased from 10.86 (Mar 23) to 15.70, marking an increase of 4.84.
For NP After MI And SOA Margin (%), as of Mar 24, the value is 15.70. This value is within the healthy range. It has increased from 10.87 (Mar 23) to 15.70, marking an increase of 4.83.
For Return on Networth / Equity (%), as of Mar 24, the value is 14.55. This value is below the healthy minimum of 15. It has increased from 9.78 (Mar 23) to 14.55, marking an increase of 4.77.
For Return on Capital Employeed (%), as of Mar 24, the value is 18.55. This value is within the healthy range. It has increased from 12.89 (Mar 23) to 18.55, marking an increase of 5.66.
For Return On Assets (%), as of Mar 24, the value is 12.36. This value is within the healthy range. It has increased from 8.28 (Mar 23) to 12.36, marking an increase of 4.08.
For Asset Turnover Ratio (%), as of Mar 24, the value is 0.80. It has increased from 0.77 (Mar 23) to 0.80, marking an increase of 0.03.
For Current Ratio (X), as of Mar 24, the value is 3.43. This value exceeds the healthy maximum of 3. It has increased from 3.30 (Mar 23) to 3.43, marking an increase of 0.13.
For Quick Ratio (X), as of Mar 24, the value is 2.18. This value exceeds the healthy maximum of 2. It has decreased from 2.24 (Mar 23) to 2.18, marking a decrease of 0.06.
For Inventory Turnover Ratio (X), as of Mar 24, the value is 1.63. This value is below the healthy minimum of 4. It has decreased from 1.85 (Mar 23) to 1.63, marking a decrease of 0.22.
For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 23) which recorded 0.00.
For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 23) which recorded 0.00.
For Earning Retention Ratio (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 23) which recorded 0.00.
For Cash Earning Retention Ratio (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 23) which recorded 0.00.
For Interest Coverage Ratio (X), as of Mar 24, the value is 109.11. This value is within the healthy range. It has increased from 73.60 (Mar 23) to 109.11, marking an increase of 35.51.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 76.62. This value is within the healthy range. It has increased from 48.42 (Mar 23) to 76.62, marking an increase of 28.20.
For Enterprise Value (Cr.), as of Mar 24, the value is 6,886.08. It has increased from 4,231.47 (Mar 23) to 6,886.08, marking an increase of 2,654.61.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 3.54. This value exceeds the healthy maximum of 3. It has increased from 2.37 (Mar 23) to 3.54, marking an increase of 1.17.
For EV / EBITDA (X), as of Mar 24, the value is 15.64. This value exceeds the healthy maximum of 15. It has increased from 14.07 (Mar 23) to 15.64, marking an increase of 1.57.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 3.56. This value exceeds the healthy maximum of 3. It has increased from 2.39 (Mar 23) to 3.56, marking an increase of 1.17.
For Retention Ratios (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 30. There is no change compared to the previous period (Mar 23) which recorded 0.00.
For Price / BV (X), as of Mar 24, the value is 3.30. This value exceeds the healthy maximum of 3. It has increased from 2.15 (Mar 23) to 3.30, marking an increase of 1.15.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 3.56. This value exceeds the healthy maximum of 3. It has increased from 2.39 (Mar 23) to 3.56, marking an increase of 1.17.
For EarningsYield, as of Mar 24, the value is 0.04. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 23) which recorded 0.04.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of FDC Ltd as of June 13, 2025 is: 401.80

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of June 13, 2025, FDC Ltd is Overvalued by 15.59% compared to the current share price 476.00

Intrinsic Value of FDC Ltd as of June 13, 2025 is: 397.19

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of June 13, 2025, FDC Ltd is Overvalued by 16.56% compared to the current share price 476.00

Last 5 Year EPS CAGR: -1.15%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock has a high average ROCE of 19.83%, which is a positive sign. The company has higher reserves (1,520.67 cr) compared to borrowings (11.75 cr), indicating strong financial stability. The company has shown consistent growth in sales (269.92 cr) and profit (277.08 cr) over the years.	The stock has a high average Working Capital Days of 40.08, which may not be favorable. The stock has a high average Cash Conversion Cycle of 101.25, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in FDC Ltd:
1. Net Profit Margin: 15.7%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 18.55% (Industry Average ROCE: 16.53%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 14.55% (Industry Average ROE: 14.7%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 76.62
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 2.18
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 29.1 (Industry average Stock P/E: 77.27)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

FDC Ltd. is a Public Limited Listed company incorporated on 23/09/1940 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24239MH1940PLC003176 and registration number is 003176. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 2070.11 Cr. and Equity Capital is Rs. 16.28 Cr. for the Year ended 31/03/2025.

INDUSTRY	ADDRESS	CONTACT
Pharmaceuticals	B-8, MIDC Industrial Estate, Chhatrapati Sambhaji Nagar Aurangabad District Maharashtra 431136	investors@fdcindia.com www.fdcindia.com

Management
Name	Position Held
CA. Uday Kumar Gurkar	Chairman & Ind.Director
Mr. Mohan A Chandavarkar	Managing Director
Mr. Nandan M Chandavarkar	Joint Managing Director
Mr. Ameya A Chandavarkar	Executive Director & CEO
Mr. Ashok A Chandavarkar	Executive Director
Ms. Nomita R Chandavarkar	Non Exe.Non Ind.Director
CA. Swati S Mayekar	Independent Director
Dr. Mahesh Bijlani	Independent Director
Mr. Vijay Maniar	Independent Director
Mr. Vijay Nautamlal Bhatt	Independent Director

FAQ

What is the intrinsic value of FDC Ltd?

FDC Ltd's intrinsic value (as of 13 June 2025) is ₹401.80 — 15.59% lower the current market price of 476.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 7,755 Cr. market cap, FY2025-2026 high/low of ₹659/359, reserves of 2,265 Cr, and liabilities of 2,714 Cr.

What is the Market Cap of FDC Ltd?

The Market Cap of FDC Ltd is 7,755 Cr..

What is the current Stock Price of FDC Ltd as on 13 June 2025?

The current stock price of FDC Ltd as on 13 June 2025 is 476.

What is the High / Low of FDC Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of FDC Ltd stocks is ₹659/359.

What is the Stock P/E of FDC Ltd?

The Stock P/E of FDC Ltd is 29.1.

What is the Book Value of FDC Ltd?

The Book Value of FDC Ltd is 140.

What is the Dividend Yield of FDC Ltd?

The Dividend Yield of FDC Ltd is 1.05 %.

What is the ROCE of FDC Ltd?

The ROCE of FDC Ltd is 16.4 %.

What is the ROE of FDC Ltd?

The ROE of FDC Ltd is 12.2 %.

What is the Face Value of FDC Ltd?

The Face Value of FDC Ltd is 1.00.